<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2017-16-3-96-100</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-285</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОТИВОЭПИДЕМИЧЕСКАЯ ПРАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ANTI-EPIDEMIC PRACTICE</subject></subj-group></article-categories><title-group><article-title>Анализ эпидемической вспышки коклюша в Республике Молдова</article-title><trans-title-group xml:lang="en"><trans-title>Pertussis Outbreak Analysis in Republic of Moldova</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Букова</surname><given-names>В. .</given-names></name><name name-style="western" xml:lang="en"><surname>Bukova</surname><given-names>V. .</given-names></name></name-alternatives><email xlink:type="simple">victoria.bucov@cnsp.md</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мельник</surname><given-names>А. .</given-names></name><name name-style="western" xml:lang="en"><surname>Melnik</surname><given-names>A. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цуркан</surname><given-names>Л. .</given-names></name><name name-style="western" xml:lang="en"><surname>Tsurcan</surname><given-names>L. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чебан</surname><given-names>А. .</given-names></name><name name-style="western" xml:lang="en"><surname>Cheban</surname><given-names>A. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуцу</surname><given-names>В. .</given-names></name><name name-style="western" xml:lang="en"><surname>Gutsu</surname><given-names>V. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Центр общественного здоровья</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center for Public Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2017</year></pub-date><volume>16</volume><issue>3</issue><fpage>96</fpage><lpage>100</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Букова В..., Мельник А..., Цуркан Л..., Чебан А..., Гуцу В..., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Букова В..., Мельник А..., Цуркан Л..., Чебан А..., Гуцу В...</copyright-holder><copyright-holder xml:lang="en">Bukova V..., Melnik A..., Tsurcan L..., Cheban A..., Gutsu V...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/285">https://www.epidemvac.ru/jour/article/view/285</self-uri><abstract><p>В статье анализируется заболеваемость коклюшем в Республике Молдова в 1993 - 2016 годах, а также рассматривается 210 из 280 случаев коклюша, зарегистрированных в 2016 году. Уменьшение охвата вакцинацией с 95,4 (2008 г.) до 89,7% (2015 г.) обусловило рост заболеваемости. В 2016 году возрастная структура заболевших выглядела следующим образом: дети в возрасте 0 - 6 лет - 68,1% (22,4% - до одного года, 44,3% - 0 - 2 лет), школьники 7 - 17 лет - 27,1% и взрослых - 4,8%. Отмечается поздняя обращаемость за медицинской помощью, в среднем через 10,5 дней после начала заболевания, в возрастной группе детей до года - 9,6 дней. Основанием для постановки диагноза «коклюш» в 10,7% случаев служили клинические данные, в 16,2% - клинико-эпидемиологические и в 73,1% - лабораторные. Специфические IgM обнаружены у 77,0 ± 6,4% больных. Среди больных до года 14,9% не достигли возраста вакцинации, 34,0% получили от 1 до 3 доз вакцины, 19,1% не привиты по ложным противопоказаниям, а 27,6% - по причине отказа. Среди больных 3 - 6 лет 56% получили 3 - 4 дозы вакцины, 18% -не привиты по причине ложных противопоказаний, а 40% - из-за отказа от вакцинации. Среди заболевших детей, получивших полный курс вакцинации против коклюша, 25,0% были привиты 1 - 2 года назад, 25,0% заболели через три - четыре года после иммунизации.</p></abstract><trans-abstract xml:lang="en"><p>There are analyzed the incidence of whooping cough for the period of 1993 - 2016 in Republic of Moldova in this article. 210 from 280 cases of pertussis reported in 2016 and. Specific IgM antibodies of 174 patients were investigated. The epidemic process of pertussis is cyclical, with a period of 3 - 4 years, with a higher incidence in urban areas and in children up to two years, with a tendency to increase the proportion among the patients of school-age children and adults. The decrease in vaccination coverage from 95.4% in 2008 to 89.7% in 2015 led to an increased incidence. From total number of cases, 68.1% were children aged from 0 to 6 years old. The age structure of registered cases in 2016 included: 22.4% under one year old; 44.3% between 1 - 2 years, 27.1% school age children between 7 -17 years and 4.8% adults. A later uptake of medical care was registered, with an average of 10.5 days after onset of the disease, but in age group of children under one year it was 9.6 days. The bases of the diagnosis of whooping cough in 10.7% of cases were clinical data, in 16.2% were clinical - epidemiological data and in 73.1% were laboratory data. Specific IgM antibodies were detected in 77.0 ± 6.4% of patients. Among patients under one year old, 14.9% were under the age of vaccination, 34.0% received from 1 to 3 doses of vaccine, 19.1% are not vaccinated by false contraindications and 27.6% due to refusal. Among patients from the age group of 3-6 years, 56.0% received 3 - 4 doses of vaccine, 18.0% were not vaccinated because of false contraindications and 40.0% due to the failure of the vaccination. From children patients who received a full course of vaccination against pertussis, 25.0% had been vaccinated 1 - 2 years ago and other 25.0% became ill after three or four years after immunization.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коклюш</kwd><kwd>заболеваемость</kwd><kwd>надзор</kwd><kwd>иммунизация</kwd><kwd>pertussis</kwd><kwd>incidence</kwd><kwd>surveillance</kwd><kwd>immunization</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pertussis vaccines: WHO position paper. Weekly epidemiological record. 2015; 35 (90): 433 - 460. Доступно на: http://www.who.int/wer.</mixed-citation><mixed-citation xml:lang="en">Pertussis vaccines: WHO position paper. Weekly epidemiological record. 2015; 35 (90): 433 – 460. Доступно на: http://www.who.int/wer.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Porteous G.H., Hanson N.A., Sueda L.A., Hoaglan C.D.,Dahl A.B, Ohlson B.B. et al. Resurgence of vaccine-preventable diseases in the United States: anesthetic and critical care implications. Anesth Analg. 2016 May; 122 (5): 1450-73. doi: 10.1213/ANE. 0000000000001196.</mixed-citation><mixed-citation xml:lang="en">Porteous G.H., Hanson N.A., Sueda L.A., Hoaglan C.D.,Dahl A.B, Ohlson B.B. et al. Resurgence of vaccine-preventable diseases in the United States: anesthetic and critical care implications. Anesth Analg. 2016 May; 122 (5): 1450–73. doi: 10.1213/ANE. 0000000000001196.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shuel M., Lefebvre B., Whyte K., Hayden K., De Serres G., Brousseau N. et al. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002 -2014. Can. J.Microbiol. 2016 May; 62 (5):437 -41. doi: 10.1139/cjm-2015-0781. Epub 2016 Jan 14.detection of a genetic shift.</mixed-citation><mixed-citation xml:lang="en">Shuel M., Lefebvre B., Whyte K., Hayden K., De Serres G., Brousseau N. et al. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002 –2014. Can. J.Microbiol. 2016 May; 62 (5):437 –41. doi: 10.1139/cjm-2015-0781. Epub 2016 Jan 14.detection of a genetic shift.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Н. И. Брико, Миндлина А.Я., Полибин Р.В. Универсальность изменений в проявлениях эпидемического процесса антропонозных инфекций за последние десятилетия. Журнал микробиологии. 2015; (5): 12 - 20.</mixed-citation><mixed-citation xml:lang="en">Briko N.I., Mindlina A.Y., Polibin R.V. Universality of changes in epidemic process manifestations of anthroponosis infections in recent decades]. Zhurnal Mikrobiologii. [Journal of Microbiology]. 2015; (5): 12 – 20 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">de Cell s M.D., Felicia M.G. Magpantay, A.A. King, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc., Biol., Sci. 2016 Jan 13; 283 (1822):20152309. doi: 10.1098/rspb.2015.2309 PMCID: PMC4721090.</mixed-citation><mixed-citation xml:lang="en">de Cellès M.D., Felicia M.G. Magpantay, A.A. King, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc., Biol., Sci. 2016 Jan 13; 283 (1822):20152309. doi: 10.1098/rspb.2015.2309 PMCID: PMC4721090.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Palazzo R., Carollo M., Bianco M., Fedele G., Schiavoni I., Pandolfi E. et al. Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination. New Microbiol. 2016 Jan; 39 (1): 35 - 47.</mixed-citation><mixed-citation xml:lang="en">Palazzo R., Carollo M., Bianco M., Fedele G., Schiavoni I., Pandolfi E. et al. Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination. New Microbiol. 2016 Jan; 39 (1): 35 – 47.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wanlapakorn N., Ngaovithunvong V., Thongmee T., Vichaiwattana P., Vongpunsawad S. et al. Seroprevalence of antibodies to pertussis toxin among different age groups in Thailand after 37 years of universal whole-cell pertussis vaccination. PLoS One. 2016 Feb 2; 11 (2): e0148338. doi: 10.1371/journal. pone.0148338. eCollection 2016.</mixed-citation><mixed-citation xml:lang="en">Wanlapakorn N., Ngaovithunvong V., Thongmee T., Vichaiwattana P., Vongpunsawad S. et al. Seroprevalence of antibodies to pertussis toxin among different age groups in  Thailand after 37 years of universal whole-cell pertussis vaccination. PLoS One.  2016 Feb 2; 11 (2): e0148338. doi: 10.1371/journal.pone.0148338. eCollection 2016.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zahn M. Just when you think you know someone: the evolving epidemiologies of measles and pertussis. Curr Opin Pediatr. 2016 Feb 28; (1): 101 - 6. doi: 10.1097/MOP.0000000000000307.</mixed-citation><mixed-citation xml:lang="en">Zahn M. Just when you think you know someone: the evolving epidemiologies of measles and pertussis. Curr Opin Pediatr. 2016 Feb 28; (1): 101 – 6. doi: 10.1097/MOP.0000000000000307.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Clarkson J.A. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Fine PE. 1982. Lancet (1): 666 - 669. doi:10.1016/S0140-6736(82)92214-0 [PubMed].</mixed-citation><mixed-citation xml:lang="en">Clarkson J.A. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Fine PE. 1982. Lancet (1): 666 – 669. doi:10.1016/S0140-6736(82)92214-0 [PubMed].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Warfel J.M., Zimmerman L.I., Merkel T.J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Natl., Acad., Sci., USA. Proc. 2014; (111): 787 - 792. doi:10.1073/pnas.1314688110 [PMC free article] [PubMed].</mixed-citation><mixed-citation xml:lang="en">Warfel J.M., Zimmerman L.I., Merkel T.J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Natl., Acad., Sci., USA. Proc. 2014; (111): 787 - 792. doi:10.1073/pnas.1314688110 [PMC free article] [PubMed].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. 2005; (24): 58 - S61. doi:10.1097/01.inf.0000160914.59160.41. [PubMed].</mixed-citation><mixed-citation xml:lang="en">Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. 2005; (24): 58 - S61. doi:10.1097/01.inf.0000160914.59160.41. [PubMed].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Phadke V.K., Bednarczyk R.A., Salmon D.A., Omer S.B. Association between vaccine refusal and vaccine-preventable diseases in the United States. A Review of Measles andPertussis. JAMA. 2016 Mar 15; 315 (11): 1149 - 58. doi: 10.1001/jama.2016.1353.</mixed-citation><mixed-citation xml:lang="en">Phadke V.K., Bednarczyk R.A., Salmon D.A., Omer S.B. Association between vaccine refusal and vaccine-preventable diseases in the United States. A Review of Measles andPertussis. JAMA. 2016 Mar 15; 315 (11): 1149 - 58. doi: 10.1001/jama.2016.1353.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Van den Biggelaar A.H., Poolman J.T. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. Expert Rev. Vaccines. 2016; 15 (1): 69 - 80. doi: 10.1586/14760584.2016.1105136. Epub. 2015; 11.</mixed-citation><mixed-citation xml:lang="en">Van den Biggelaar A.H., Poolman J.T. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. Expert Rev. Vaccines. 2016; 15 (1): 69 - 80. doi: 10.1586/14760584.2016.1105136. Epub. 2015; 11.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell P.T., McCaw J.M., McIntyre P. Defining long-term drivers of pertussis resurgence and optimal vaccine control strategies McVernon J. Vaccine 2015 Oct 26; 33 (43): 5794 - 800. doi:10.1016/j.vaccine. 2015.09.025. Epub 2015 Sep 19.</mixed-citation><mixed-citation xml:lang="en">Campbell P.T., McCaw J.M., McIntyre P. Defining long-term drivers of pertussis resurgence and optimal vaccine control strategies McVernon J. Vaccine 2015 Oct 26; 33 (43): 5794 - 800. doi:10.1016/j.vaccine. 2015.09.025. Epub 2015 Sep 19.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Koh M.T., Liu C.S., Chiu C.H., Boonsawat W., Watanaveeradej V., Abdullah N. et al., Under-recognized pertussis in adults from Asian countries: a crosssectional seroprevalence study in Malaysia, Taiwan and Thailand. Epidemiol. Infect. 2016 Apr 14; 4 (6): 1192 - 1200. doi: 10.1017/S0950268815002393. Epub 2015 Oct 15.</mixed-citation><mixed-citation xml:lang="en">Koh M.T., Liu C.S., Chiu C.H., Boonsawat W., Watanaveeradej V., Abdullah N. et al., Under-recognized pertussis in adults from Asian countries: a crosssectional seroprevalence study in Malaysia, Taiwan and Thailand. Epidemiol. Infect. 2016 Apr 14; 4 (6): 1192 - 1200. doi: 10.1017/S0950268815002393. Epub 2015 Oct 15.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin., Infect., 1999; Dis.28 (Suppl, 2): 112 - 117. doi:10.1086/515058. [PubMed].</mixed-citation><mixed-citation xml:lang="en">Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin., Infect., 1999; Dis.28 (Suppl, 2): 112 - 117. doi:10.1086/515058. [PubMed].</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">von Knig C.H.W., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect., Dis. 2002; (2): 744 - 750. doi:10.1016/S1473-3099(02)00452-8. [PubMed].</mixed-citation><mixed-citation xml:lang="en">von Knig C.H.W., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect., Dis. 2002; (2): 744 - 750. doi:10.1016/S1473-3099(02)00452-8. [PubMed].</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. 2010; Evol. (10): 36 - 49. doi:10.1016/j.meegid.2009.10.007. [PubMed].</mixed-citation><mixed-citation xml:lang="en">Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. 2010; Evol. (10): 36 - 49. doi:10.1016/j.meegid.2009.10.007. [PubMed].</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bart M.J. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. 2014; mBio 5, e01074. doi:10.1128/ mBio.01074-14. [PMC free article]. [PubMed].</mixed-citation><mixed-citation xml:lang="en">Bart M.J. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. 2014; mBio 5, e01074. doi:10.1128/ mBio.01074-14. [PMC free article]. [PubMed].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
